CEDAR KNOLLS, N.J., March 30, 2011 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that management will host a conference call to discuss the Company's financial and ...
CEDAR KNOLLS, N.J., June 17, 2011 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that Novartis informed Emisphere of the results of its recently completed Proof of ...
ROSELAND, N.J., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCMKTS: EMIS) today announced that Alan L. Rubino, will retire as President and Chief Executive Officer (CEO) ...
CEDAR KNOLLS, N.J., Sep 17, 2010 (GlobeNewswire via COMTEX News Network) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that a clinical study found that the company's proprietary oral ...
Novo Nordisk on Tuesday said it completed the previously announced acquisition of Roseland-based Emisphere Technologies Inc. for $1.35 billion. The consideration paid was $7.83 per share, which was ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CEDAR KNOLLS, N.J., Dec. 8, 2008 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (NasdaqCM:EMIS - News), a biopharmaceutical company that focuses on an improved delivery of therapeutic molecules ...
CEDAR KNOLLS, N.J., July 8 EmisphereTechnologies, Inc. (Nasdaq: EMIS) today announced findings from a clinicalstudy assessing the oral delivery of GLP-1 peptide safely and effectively. Thestudy used a ...
Emisphere Technologies said today it will develop and commercialize oral formulations of four classes of Novo Nordisk investigational molecules targeting major metabolic disorders—including diabetes ...
CEDAR KNOLLS, N.J., March 19 EmisphereTechnologies, Inc. (Nasdaq: EMIS) released today results of additional animalstudies demonstrating that its proprietary eligen(R) technology enhances ...
In its first license agreement for small-molecule compounds, Emisphere Technologies Inc. signed on with F. Hoffmann-La Roche Ltd. to develop oral formulations of approved therapies for bone-related ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...